Four Thought Financial Partners, LLC Astrazeneca PLC Transaction History
Four Thought Financial Partners, LLC
- $777 Billion
- Q2 2024
A detailed history of Four Thought Financial Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Four Thought Financial Partners, LLC holds 88,858 shares of AZN stock, worth $7.38 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
88,858
Previous 88,743
0.13%
Holding current value
$7.38 Million
Previous $6.01 Billion
15.26%
% of portfolio
0.89%
Previous 0.69%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,331Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.39 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.54 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.37 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$3.05 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.46 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $257B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...